Quadria Capital waives buyback right to exit Indian drugmaker

Premium

Singapore- and Delhi-based private equity firm Quadria Capital, which is on the road to raise up to $1 billion for its third fund, has waived its right to exit an Indian drugmaker by selling its shares back to the company’s founders.  The healthcare-focused PE firm had in February this year set ......